ATRUVIQ Trademark

Trademark Overview


On Thursday, July 25, 2019, a trademark application was filed for ATRUVIQ with the United States Patent and Trademark Office. The USPTO has given the ATRUVIQ trademark a serial number of 88537146. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, June 6, 2020. This trademark is owned by QED Therapeutics, Inc.. The ATRUVIQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations and substances for the treatment of cancer and skeletal abnormalities

conducting research and development in the fields of cancer and skeletal abnormalities
atruviq

General Information


Serial Number88537146
Word MarkATRUVIQ
Filing DateThursday, July 25, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, June 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations and substances for the treatment of cancer and skeletal abnormalities
Goods and Servicesconducting research and development in the fields of cancer and skeletal abnormalities

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 2, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQED Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94017

Trademark Events


Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, June 6, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 17, 2019NON-FINAL ACTION E-MAILED
Thursday, October 17, 2019NON-FINAL ACTION WRITTEN
Wednesday, October 16, 2019ASSIGNED TO EXAMINER
Friday, August 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 29, 2019NEW APPLICATION ENTERED IN TRAM